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Abstract
Background: Transcription factor-dependent cellular reprogramming is integral to normal development and is
central to production of induced pluripotent stem cells. This process typically requires pioneer transcription factors
(TFs) to induce de novo formation of enhancers at previously closed chromatin. Mechanistic information on this
process is currently sparse.
Results: Here we explore the mechanistic basis by which GATA3 functions as a pioneer TF in a cellular
reprogramming event relevant to breast cancer, the mesenchymal to epithelial transition (MET). In some instances,
GATA3 binds previously inaccessible chromatin, characterized by stable, positioned nucleosomes where it induces
nucleosome eviction, alters local histone modifications, and remodels local chromatin architecture. At other loci,
GATA3 binding induces nucleosome sliding without concomitant generation of accessible chromatin. Deletion of
the transactivation domain retains the chromatin binding ability of GATA3 but cripples chromatin reprogramming
ability, resulting in failure to induce MET.
Conclusions: These data provide mechanistic insights into GATA3-mediated chromatin reprogramming during
MET, and suggest unexpected complexity to TF pioneering. Successful reprogramming requires stable binding to a
nucleosomal site; activation domain-dependent recruitment of co-factors including BRG1, the ATPase subunit of the
SWI/SNF chromatin remodeling complex; and appropriate genomic context. The resulting model provides a new
conceptual framework for de novo enhancer establishment by a pioneer TF.
Keywords: GATA3, Mesenchymal-to-epithelial transition, Breast cancer, Pioneer factor, Chromatin remodeling,
Enhancer establishment
Background
Transcription factors (TFs) are utilized throughout life
as a means of regulating transcriptional output. The
human genome encodes somewhere between 1,500 and
2,000 TFs [1], making them one of the more abundant
protein classes. These proteins recognize DNA motifs in
and around genes and alter RNA synthesis through a
variety of mechanisms [2, 3]. Classification based on
structures of their DNA-binding domains provides
cardinal insights into their modes of DNA recognition.
While structural studies have advanced our understanding
of how TFs interact with DNA, genomic studies of their
localization indicate that the vast majority of potential TF
binding sites are not occupied in vivo [4–6].
In eukaryotes, genomic DNA is packaged into nucleo-
somes, the fundamental unit of chromatin structure.
Nucleosomal architecture presents a barrier to success-
ful protein-DNA interactions for many TFs [7–9].
Pioneer TFs represent an exception to this general rule;
these proteins have the ability to interact productively
with DNA in a nucleosomal context. Pioneer factors
have at least three fundamental properties as recently
described by Iwafuchi-Doi and Zaret [10]: (1) they can
interact with their cognate recognition sequences in
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nuclease-resistant chromatin prior to activation of tran-
scription; (2) they increase local chromatin accessibility
as a prelude to productive binding of other factors; and
(3) they have integral roles in the establishment of cell
lineage. FOXA1 represents a prototypical example of a
pioneer TF; FOXA1 can bind nucleosomal DNA in vitro,
and target closed chromatin regions in vivo which subse-
quently become accessible and permissive for productive
binding of other factors [5, 11–13]. FOXA1 is required
for multiple developmental lineage commitment choices
including those leading to development of liver, lung,
and mammary gland [13–17]. Other TFs involved in
reprogramming of somatic cells to pluripotency such as
Oct4, Sox2, and Klf4, also function as pioneer factors
utilizing unique adaptations of their DNA recognition
surfaces to accommodate nucleosome structure, which
likely represents a common genome interrogation mech-
anism of the pioneer class [18, 19]. FOXA1 has struc-
tural similarity to linker histone [20, 21], therefore it is
thought to compete with linker histone [12]. However
validated pioneer factors exhibit large structural diversity in
sequence-recognition domains, mechanism(s) underlying
chromatin opening may vary.
DNA-binding proteins that have zinc finger domains
compose the most abundant protein family in eukaryotic
genomes [22]. The vertebrate GATA family proteins,
which possess two zinc-finger domains, play critical
roles across development and differentiation, contribut-
ing to lineage commitment. They also possess several
hallmark features, as a family, of pioneer TFs: several
family members can bind to nucleosomal DNA and in-
duce accessibility, both in vivo and in vitro [11, 23–29].
Importantly the DNA-binding domains of GATA family
proteins are structurally distinct from FOXA1, implying
that mechanism(s) to create open chromatin may differ.
While elegant evidence supports an intrinsic capacity of
FOXA1 to remodel chromatin without the assistance of
co-factors [11], it remains unclear how and whether
GATA proteins induce similar structural alterations.
In this study, we focus on the human GATA3 protein,
which is the only human GATA family member whose
DNA-binding domain has been crystallized [30]. GATA3
is a key regulator of multiple developmental pathways in-
cluding mammary epithelial cell differentiation, T lympho-
cyte development, and trophoblast development [31–34].
GATA3 is implicated in breast cancer progression, and re-
cently has been identified as one of the most frequently
mutated genes in breast cancer [35]. A considerable num-
ber of clinical studies have demonstrated that reduced
expression level of GATA3 correlates with poor prognosis
[36]. Consistent with the in vivo data, GATA3 exerts me-
tastasis suppressive functions when expressed exogenously
in a human basal-like breast cancer cell line by inducing
the mesenchymal-to-epithelial transition (MET) [37–39].
Although this transition is accompanied by gene expres-
sion reprogramming including microRNA induction [37],
the molecular mechanisms underlying this cell repro-
gramming process at the chromatin level are incompletely
understood. In other contexts, GATA3 is known to repro-
gram fibroblasts to induced pluripotent stem cells (iPSCs)
[40] as well as induced trophoblast stem cells (iTSCs) [41,
42] in collaboration with other TFs, implying a potential
role for GATA3 in chromatin reprogramming.
In order to investigate the impact(s) of GATA3 on
chromatin, we utilized the MET model in the MDA-
MB-231 breast cancer cell line. Consistent with previous
results, GATA3 expression induced mesenchymal-to-
epithelial transition at the cellular and molecular level
and mediated reprogramming of chromatin at genes in-
tegral to MET. Our studies provide experimental evi-
dence that GATA3 can direct alterations in local
chromatin during the MET reprogramming process, in-
cluding pioneer factor activity, that differ depending on
local context and that these alterations proceed through
an intermediate consisting of nucleosomal DNA bound
by a pioneer factor.
Results
GATA3 binding sites acquire open chromatin structure
and enhancer-like histone modifications
To investigate chromatin reprogramming during the
MET process, we utilized MDA-MB-231 breast cancer
cells, in which GATA3, and its known partners, FOXA1
and estrogen receptor-α, are below limits of detection at
the protein level. Previous work has demonstrated that
ectopic expression of GATA3 promotes cell reprogram-
ming (MET) in MDA-MB-231 cells with an alteration in
metastatic capacity [37–39]. We first established stable
cell lines expressing wild-type GATA3 at levels com-
parable to that found in GATA3-positive breast can-
cer cells (Additional file 1: Figure S1A). As expected,
GATA3-expressing cells were reprogrammed, exhibit-
ing phenotypic changes at the cellular and molecular
level (Additional file 1: Figure S1B, S1C). In order to
determine the genomic distribution of GATA3 in MDA-
MB-231 cells, we performed ChIP-seq analyses, identify-
ing 43,504 peaks of enrichment (Fig. 1a; Additional file 1:
Figure S1D). GATA3 localization following exogenous
expression in MDA-MB-231 cells was compared to the
pattern previously observed in the luminal epithelial
breast cancer cell lines T47D and MCF7 [43]. We detected
a large number of cell type specific binding sites along
with many binding sites that overlapped those in GATA3-
positive cell lines (Fig. 1a; Additional file 1: Figure S1E).
De novo motif analysis of the peaks in MDA-MB-231 cells
revealed significant enrichment of the GATA3 consensus
binding site (Fig. 1a). Therefore we concluded that
GATA3 bound to chromatin in MDA-MB-231 cells, and
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Fig. 1 Chromatin domain bound by GATA3 becomes more accessible together with increased levels of enhancer-like histone marks. a Genomic
localization of GATA3 across three breast cancer cell lines. UCSC Genome Browser snapshot showing the mapped read coverage of GATA3
ChIP-seq in MDA-MB-231 (blue), MCF7 (green), and T47D cells (red). The top motif identified by HOMER de novo motif analysis is represented at
the right with P values. b Representative genomic loci acquired DNA accessibility. The GATA3-binding sites displayed: (top) significant increased
level or (bottom) de novo peaks of ATAC-seq, H3K4me1, and H3K27ac signals after ectopic expression of GATA3. The other example loci are
shown in Additional file 1: Figure S1. Metagene profiles of normalized ATAC-seq (c), H3K4me1 ChIP-seq (d), and H3K27ac ChIP-seq (e) are shown
to compare the average signal levels centered on GATA3 ChIP-seq peaks in control and GATA3 expressing cells. The GATA3 peaks are divided into
TSS-proximal (less than or equal to 1 kb) or distal (more than 1 kb) peaks based on the distance
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this system likely captures critical regulatory features of
cellular reprogramming from a mesenchymal state to an
epithelial one.
Pioneer factors are characterized by their ability to bind
to previously ‘closed’ chromatin and elicit a chromatin
state change. To evaluate the impact of GATA3 on chro-
matin structure, we measured chromatin accessibility in
MDA-MB-231 cells with and without GATA3 expression
using ATAC-seq [44]. At the individual locus level, many
GATA3-binding sites including MET associated gene loci
exhibited increased accessibility in GATA3-expressing
cells (hereafter MDA231-GATA3 cells) (Fig 1b; Additional
file 1: Figure S1F). Across the genome, TSS-distal peaks
(greater than 1 kb from nearest TSS) exhibited a sig-
nificant difference (P values < e-10) between control
and MDA231-GATA3 cells (Fig. 1c). Randomly se-
lected GATA motif containing regions showed similar
levels of transposase sensitivity between control and
GATA3-expressing cells, indicating that overall trans-
posase integration efficiencies were similar (Additional
file 1: Figure S1G). To dissect the function of chro-
matin domains bound by GATA3, we investigated histone
modifications typically associated with active chromatin at
enhancers, such as H3K4 monomethylation (H3K4me1)
and H3K27 acetylation (H3K27ac). Similar to the ATAC-
seq results, H3K4me1 and H3K27ac levels in MDA-231-
GATA3 cells were drastically increased at TSS distal
GATA3 peaks (Fig. 1d, e).
Chromatin structure based classification reveals a pioneer
class of binding sites
To dissect the chromatin bound by GATA3, we classified
the GATA3 peaks into four groups based on ATAC-seq
signal changes before and after the epithelial transition. At
a FDR <0.1, fold change >2, 11,035 GATA3 peaks (25 %)
became sensitive to the transposase (Fig. 2a, G1). A total
of 1,426 binding sites (3 %) displayed decreased levels of
ATAC-seq signals following GATA3 expression (Fig. 2a,
G4). The majority of binding sites (31,043 peaks, 71 %)
did not change transposase sensitivity; these sites were
subclassified into signal positive (19,585 loci, 45 %) and
negative (11,458 loci, 26 %) groups based on the signal
intensity in control cells (cutoff: read counts <20) (Fig. 2a,
G2 and G3). We also interrogated histone marks in each
group. Heatmap and metagene plot analyses revealed that
the category with increased ATAC sensitivity, G1, had
increased levels of H3K4me1 and H3K27ac following
GATA3 expression (Fig. 2a-d). The signal conserved
groups (G2 and G3) showed modest increases in the level
of H3K4me1 and H3K27ac (Additional file 1: Figure S2D,
S2E, S2G, S2H). The class of loci where accessibility de-
creased exhibited decreases in both H3K4me1and
H3K27ac (Additional file 1: Figure S2C, S2F, S2I). These
analyses demonstrate that GATA3-bound loci can be
classified based on whether or not they were previously
accessible and whether local chromatin was altered fol-
lowing introduction of GATA3. One category, G1, exhibits
the hallmark properties expected for pioneering activity.
To elucidate the correlation between gene expression
and GATA3 binding, we assigned GATA3 peaks to
target genes using a simple distance metric, and mea-
sured the impact of GATA3 on gene expression using
RNA-seq. GATA3-binding events in category G1 were
enriched for increased gene expression, and the ratio of
the genes categorized as upregulated was higher in G1
than that in G2 and G3 (Additional file 1: Figure S3A-D).
Interestingly, target genes in G1 contain transcripts
indicative of reprogramming of MDA-MB-231 to an
epithelial identity, such as KRT8, KRT18, CDH1, and
CLDN3 (Additional file 2: Table S1). When analyzed
over time following exogenous expression of GATA3
using lentivirus, a subset of those genes were upregu-
lated within 48-96 h after the induction of GATA3
(Additional file 1: Figure S3E). Functional pathway
analysis of genes found in G1 featured enrichment in
genes integral to the MET and to maintenance of
epithelial identity (Additional file 1: Figure S3F).
These functional categories were not enriched in G3
(Additional file 1: Figure S3G, Additional file 2: Table
S1), suggesting that GATA3 binding and chromatin
opening at G1 sites is integral to the MET, consistent
with function as a pioneer.
GATA3 remodels local nucleosome structure
Mechanistically, it was unclear why GATA3 binding at
previously inaccessible loci, as detected by ChIP-seq,
should sometimes, but not always, result in formation of
accessible chromatin. Therefore, we sought to under-
stand why GATA3 could open chromatin structure only
at G1 sites but not at G3 sites. To address this question,
we compared the enrichment of GATA3 between these
groups. The open chromatin loci within categories G1 and
G2 had similar enrichment of GATA3; the transposase-
inaccessible loci bound by GATA3 in category G3 clearly
displayed lower enrichment (Fig. 2e; Additional file 1:
Figure S2J), suggesting a fundamental difference in the
interaction of GATA3 with its cognate recognition
element at these two classes of sites. These observed
differences in ChIP-seq read level could result from differ-
ences in inherent affinity driven by local DNA sequence.
Alternatively, they could result from interaction of GATA3
with nucleosomal DNA (G3) fundamentally differing from
interaction with accessible chromatin (G1 and G2). Fi-
nally, the differences in enrichment could result from
differential association with co-factors, such as the
Friend of GATA proteins [45, 46] or other partners.
Investigating the genes differentially expressed in our
system (Additional file 1: Figure S1C), 108 known TFs
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were upregulated in MDA-231-GATA3 cells, and two
TF motifs were co-enriched in category G1, indicating
the potential for cooperative action at a subset of sites
(Additional file 3: Table S2).
Qualitatively, consensus motifs derived from the loci
in G1 did not differ substantially from those in G3
(Additional file 1: Table S3), suggesting differences in
binding do not result from deviation of recognition
elements from consensus. Accordingly, we hypothesized
that the observed difference in enrichment might result
from either difference in co-factor association or from
difference in substrate quality when comparing nucleo-
somal DNA to disrupted chromatin. Either of these two
possible outcomes should result in an alteration in
apparent binding affinity at categories G1 and G2 when
compared to category G3. To test this hypothesis, we
asked whether increasing thermodynamic entropy would
differentially impact category G3 as opposed to categor-
ies G1 and G2. Accordingly, we briefly incubated nuclei
at 37o C or on ice in physiological salt prior to cross
linking and performed ChIP-seq. We observed that
binding events in category G3, and only G3, were signifi-
cantly diminished by increasing temperature (Fig. 2f, g,
Additional file 1: Figure S2K, S2L). These data suggest
that the on and off rate constants at category G3 differ
from those at categories G1 and G2. This scenario is
consistent with a model wherein category G3 represents
GATA3 bound at its recognition site in the context of
canonical nucleosomal architecture whereas categories
G1 and G2 fundamentally differ in the nature of the
substrate. Utilizing our previous ChIP-seq data [43] and
ENCODE DNase-seq data [2], we confirmed the pres-
ence of a category of G3-like GATA3 bound sites in
luminal breast cancer cells (T47D and MCF7 cells)
(Additional file 1: Figure S2M, S2N). Of the GATA3
peaks, 51 % (in the case of MCF7) and 37 % (in the case
of T47D) did not overlap with DNase-seq peaks in these
cells, suggesting the existence of loci that are bound by
GATA3 but not accessible, like category G3 in the
MDA-231 reprogramming system, is unlikely to be an
artefact of expression out of normal context.
To further explore this model, we determined the nucleo-
somal architecture of GATA3-binding sites by MNase-seq
before and after GATA3 expression. As expected, pre-open
chromatin regions (G2) exhibited the typical chromatin
structure frequently observed at TF-binding sites (Fig. 3b).
The center of the GATA3 peak has lower nucleosome
density (so called nucleosome-depleted regions) flanked on
each side by higher nucleosome density; this structure
was conserved after the introduction of GATA3
(Fig. 3b). Notably, in the absence of GATA3, target
sites in G1 presented high nucleosome density over
the GATA3 peak, suggesting GATA3 may target re-
gions occupied by nucleosomes (Fig. 3a). At these loci,
GATA3 binding led to eviction of the nucleosome
positioned over the GATA3 binding site with con-
comitant production of phased nucleosomes flanking
the GATA3 site - similar to the profile observed in G2.
Binding sites in G3 displayed a regular array of nucle-
osomes in the absence of GATA3. At these loci,
GATA3 expression led to nucleosome sliding such that
the nucleosome array, while still present, was shifted
relative to DNA sequence (Fig. 3c).
The cellular data above suggested that GATA3 may
bind to nucleosomes within regions of closed chromatin.
To test this hypothesis, we first generated a model struc-
ture of a GATA3-bound nucleosome by utilizing crystal
structure information [30, 47] for the nucleosome and
for the GATA3 DNA binding domain (DBD) (Fig. 3d).
In the resulting model, the GATA3-DNA complex was
aligned by the ‘GATA’ sequence found within the 601-
nucleosome positioning sequence [48]. An appreciable
structural barrier to binding was not observed in this
model. Therefore, we reconstituted nucleosomes on
601-based DNAs with or without the consensus GATA
motif using recombinant human histones (Fig. 3d, e).
We also purified the DNA binding domain of GATA3
from engineered bacteria, and performed gel shift ana-
lyses (Fig. 3f, g). In the presence of its binding motif,
GATA3 displayed discrete shifted bands, suggesting
specific binding to the nucleosomal target (Fig. 3g, lanes
1 to 3). However, in the absence of the motif, the bind-
ing affinity was significantly reduced and appeared to be
non-specific (Fig. 3g, lanes 5 to 7). In both cases, the use
of excess amounts of protein resulted in non-specific
nucleosome binding (Fig. 3g, lanes 4 and 8). We thus
(See figure on previous page.)
Fig. 2 Identification and characterization of ‘Pioneer’ sites bound by GATA3. a Read density heatmaps showing the signal enrichment of GATA3
ChIP-seq, ATAC-seq, H3K4me1, and H3K27ac ChIP-seq. Classification from G1 to G4 was carried out based on ATAC-seq signal changes between
control and GATA3 expressing cells. The number of peaks in each category is reported below the group label. Each row indicates a 10 kb window
centered on a GATA3 binding site. The scale of read density after normalization (see Additional file 1: Table S6) is indicated at the bottom right.
Metagene profiles of normalized ATAC-seq (b), H3K4me1 ChIP-seq (c), and H3K27ac ChIP-seq (d) in G1 are shown for the comparison of the
average signal levels in control and GATA3 expressing cells. Metagene profiles in the other groups are shown in Additional file 1: Figure S2.
e The signal enrichment of GATA3 ChIP-seq in each group is shown as a box-and-whisker plot. The top and bottom whiskers show 5th and 95th
percentile, respectively. The horizontal line and cross mark the median and mean. *P <0.0001, Mann-Whitney test. Metagene plots of normalized
tag density of GATA3 ChIP-seq in G1 (f) and G3 (g) performed with or without thermal treatment at 37 °C. The metagene plot in G2 and the
quantitative analysis are represented in Additional file 1: Figure S2
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concluded that GATA3 can interact productively with its
target recognition sequence within the context of a
nucleosome, consistent with function as a pioneer.
Transactivation domain is required for GATA3-mediated
chromatin remodeling
The biochemical experiments with purified proteins
suggested the DNA-binding domain was sufficient to
bind to nucleosomal DNA. To identify the functional
domain(s) required for GATA3-mediated chromatin re-
modeling, we established MDA-MB-231 cells expressing a
mutant version of GATA3 lacking one of the previously-
defined transactivation domains [49] (Fig. 4a). The average
expression level of this mutant was equivalent to wild-type
GATA3 (Additional file 1: Figure S4A, S4C, S4D). Import-
antly, cells expressing this mutant version of GATA3 fail to
reprogram to an epithelial phenotype at the cellular and
molecular level (Additional file 1: Figure S4B, S4D). We
then defined the genome-wide distribution of this mutant
by ChIP-seq, using the Ty1 epitope tag. We observed that
ChIP-seq signals of wild-type and mutant versions of
GATA3 were similar (Fig. 4b; Additional file 1: Figure S4E,
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Fig. 3 GATA3 induces nucleosome reorganization by targeting nucleosomal DNA. Metagene plots of normalized tag density of MNase-seq in G1
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S4F). Although a number of differential binding peaks were
detected, many enriched binding sites were conserved
between wild-type GATA3 and the TA1 mutant (Fig. 4b, c;
Additional file 1: Figure S4G). We have limited subsequent
analyses to those peaks found in both datasets. The consen-
sus GATA3 motif was also enriched at loci bound by the
TA1 mutant (Fig. 4d). Surprisingly, remodeling of chroma-
tin structure and induction of histone modification was
virtually abolished by deletion of the amino-terminal trans-
activation domain (Fig. 4e, f, Additional file 1: Figure S1F).
We performed peak classification using parameters identi-
cal to those used in Fig. 2a, finding only 327 sites (<1 %,
11,035 sites in the case of wild-type) which were catego-
rized as increasing accessibility following mutant GATA3
expression (Additional file 1: Figure S5).
In order to compare wild-type and mutant versions of
GATA3, we focused on binding sites where both wild-
type and the mutant were co-localized finding 23,263
peaks were shared between the two datasets (Fig. 4c).
We observed that the TA1 mutant version of GATA3
failed to induce accessibility at loci where wild-type
GATA3 did (Fig. 5a, b, Additional file 1: Figure S5B-D).
In addition, mutant GATA3 failed to induce local
histone modifications at these loci (Fig. 5c, d, Additional
file 1: Figure S5E-J). We also noted that the ChIP-seq
tag density of the mutant in category G1 (but not G2
and G3) was decreased when compared to wild-type
GATA3 (Additional file 1: Figure S6), and was nearly
identical to the density of the mutant in G3 (Additional
file 1: Figure S6D). Further, the number of loci at which
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both wild-type and mutant versions co-localized was
substantially lower in the pioneer category G1 as com-
pared to categories G2 and G3 in which accessibility is
not impacted by GATA3 binding (Figs. 2a and 6a).
Although this truncation mutant possesses an intact
DNA-binding domain, these data suggested that the
mutant is impaired in pioneer activity. To further
explore local chromatin architecture in wild-type versus
mutant GATA3 expressing cells, we compared the
MNase-seq signals in each cell line. The digestion
patterns in the mutant-expressing cells were similar to
those in control cells (Fig. 5e-g). The nucleosome occu-
pancy at the GATA3 binding sites in category G1 was
largely unchanged in the presence of the TA1 mutant,
indicating a failure in nucleosome eviction (Fig. 5e).
Further, at loci within category G3, the TA1 mutant
failed to initiate nucleosome sliding around the center of
the peak (Fig. 5g). These results suggested that the N-
terminal transactivation domain (1-125aa) of GATA3 is
critical for GATA3-mediated chromatin remodeling and
the induction of histone modifications.
GATA3 interacts with BRG1, a chromatin remodeling
factor in solution and on chromatin
The inability of mutant GATA3 to remodel chromatin
suggested that either the transactivation domain has
chromatin remodeling activity similar to the carboxyl-
terminal domain of FOXA1 [11], or that this region
functions as a platform to recruit co-factors. Enrichment
analysis of genes assigned to the G1 group identified the
BRG1/SMARCA4 chromatin remodeling factor as a
candidate co-factor (Additional file 1: Table S4). BRG1 is
also known to function with the other GATA family
proteins such as GATA1 and GATA4 [23, 50, 51] and is
characterized by its ability to evict nucleosomes [52–54].
Therefore we asked whether BRG1 and GATA3 had
biochemical interactions. We prepared conventional
nuclear extracts from MDA-MB-231 cells expressing
GATA3. Co-immunoprecipitation analysis indicated
solution interactions between GATA3 and BRG1 in the
MDA-MB-231 context (Fig. 6a). This interaction was
further confirmed by co-immunoprecipitation of the en-
dogenous proteins from T47D cells (Fig. 6b). Accordingly,
we explored BRG1 accumulation at GATA3 binding sites
in our MDA-MB-231 system using ChIP-seq for endogen-
ous BRG1. We observed consistent enrichment of BRG1
at GATA3 binding sites in cells expressing wild-type, but
not mutant, GATA3 at loci where GATA3 functions as a
pioneer and evicts nucleosomes (Fig. 6c-e; Additional file
1: Figure S6E, S6F). These data demonstrate that BRG1
recruitment correlates with GATA3-dependent nucleo-
some eviction in a manner dependent on local context
and on the GATA3 amino terminal activation domain.
Discussion
Information content embedded in eukaryotic chromo-
somes modulates transcriptional output, influencing the
transcriptional patterns integral to biological processes.
A critical unit of this information is the TF-DNA
complex, which can modulate the gene expression net-
work at multiple levels. TFs receive instruction from
local DNA sequence, reading the DNA backbone and
the functional groups protruding into the major and
minor grooves to recognize specific binding sites in
genomic DNA. In eukaryotic nuclei, this paradigm is
complicated by the packaging of DNA into chromatin
which regulates access to the chemical moieties on DNA
that drive productive TF-DNA recognition events.
Integral to the elaboration of cell type and specialized
function is a requirement for certain TFs to penetrate
previously inaccessible chromatin leading to new patterns
of transcriptional output.
In this report, we provide detailed analysis of GATA3-
mediated chromatin reprogramming in the context of
MET in a system relevant to breast cancer; we observed
several key outcomes. At approximately 25 % of bound
loci (category G1), GATA3 has the capacity to pioneer
new binding sites in previously inaccessible chromatin
that features high nucleosome occupancy over the
GATA motif prior to GATA3 expression. At approxi-
mately 45 % of bound loci (category G2), GATA3 binds
to a motif located within accessible chromatin where it
appears to modestly increase the width of the accessible
region. Surprisingly, we observed another 25 % of bound
loci (category G3) where GATA3 occupancy is clearly
detected by ChIP-seq, but where the local chromatin
architecture remains refractory to transposition follow-
ing GATA3 binding. Biochemical experiments suggested
(See figure on previous page.)
Fig. 5 Transactivation domain is required for chromatin reprogramming. a Read density heatmaps showing the signal enrichment of Ty1 ChIP-seq,
ATAC-seq, H3K4me1, and K27ac ChIP-seq in control, wild-type, and mutant GATA3 expressing cells. The same classification was utilized, but only the
sites where both wild-type and mutant were localized are represented. The number of peaks in each category is reported. Each row indicates a 10 kb
window centered on a GATA3 binding site. The scale of read density after normalization is indicated at the bottom right. Metagene profiles of
normalized ATAC-seq (b), H3K4me1 ChIP-seq (c), and H3K27ac ChIP-seq (d) in G1 are shown for the comparison of the average signal levels in
control, wild-type GATA3, and TA1del mutant expressing cells. Metagene profiles in the other groups are shown in Additional file 1: Figure S5.
Metagene profiles of normalized MNase-seq signal density in G1 (e), G2 (f), and G3 (g) are shown, respectively. Top panels indicate the comparison
between control and wild-type GATA3 expressing cells. Bottom panels indicate the comparison between control and TA1 del mutant expressing cells.
Only overlapped peaks between wild-type and mutant GATA3 were used for the metagene analyses (b-g)
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that protein-DNA interactions at the latter category of
bound loci – where GATA3 binds to inaccessible
chromatin and fails to remodel local architecture to a
transposition-permissible state – were fundamentally
different than the other two major categories. GATA3
could be functioning to alter chromatin and transcrip-
tional status at both category G1 and G2, however
category G2 sites were already open and did not exhibit
drastic differences in chromatin architecture following
expression of GATA3. Because of this limitation, we
focused on the functional properties of binding events in
category G1 and G3. We interpret the data to support a
model for GATA3 interaction with chromatin. We
envision that the protein scans the chromatin fiber for
consensus binding motifs where the chemical moieties
involved in productive interaction are positioned relative
to the nucleosome surface in a manner providing access
for interrogation by protein. Recognition of a productive
binding site within a nucleosomal context engenders
formation of a GATA3/nucleosome complex, a species
we are able to recapitulate in vitro (Fig. 3d-g). At a
subset of such sites, GATA3 is able to initiate nucleo-
some eviction over the center of the binding site with
subsequent generation of flanking arrays of positioned
nucleosomes bearing the hallmarks of an active enhan-
cer (Fig. 2). Such sites are characterized by the GATA3-
dependent generation of chromatin accessible to the
structural probes sampled here, and by acquisition of
active enhancer histone marks. At other sites, GATA3 is
able to productively bind as measured by ChIP-Seq. In
contrast to category G1 loci, these category G3 sites are
characterized both before and after GATA3 binding by a
nucleosome array which slightly slide relative to DNA
sequence following expression of GATA3. These sites
exhibit no evidence of nucleosome eviction over the
binding site and do not generate accessible chromatin.
We propose that association of co-factors to a GATA3/
nucleosome complex differs in a context-dependent
manner and that the nature of specific co-factors funda-
mentally alters outcome. At pioneering loci, the action
of co-factors including the SWI/SNF complex alters the
protein/substrate interaction, leading to nucleosome
eviction and generation of accessible chromatin (Fig. 2e, f).
At category G3, other co-factors lead to nucleosome
sliding, repositioning an array of nucleosomes relative to
DNA sequence without generation of accessibility. In both
instances, alterations in local chromatin are dependent on
the presence of the activation domain.
The model proposed here envisions two distinct steps
to pioneering activity by GATA3 – binding followed by
local remodeling – and differs from that explaining the
pioneering activity of FOXA1. Elegant biochemical and
cellular data suggest that FOXA1 has the intrinsic cap-
acity to elicit local perturbation of chromatin structure
without the involvement of additional co-factors [11].
Pioneering activity by GATA3, on the other hand, corre-
lates with the capacity to recruit the mammalian SWI/
SNF chromatin remodeling complex and requires the
presence of the transcriptional activation domain (Figs. 5
and 6). While local remodeling by FOXA1 appears inex-
tricably linked to productive binding, GATA3 appears to
require co-factors for this function. A critical question
arises as to why GATA3 binding leads to distinct
outcomes at different loci despite the observation of a
biochemical interaction between GATA3 and BRG1. It is
possible that this interaction alone is not sufficient to
drive the initiation of nucleosome eviction at all loci; it
is also conceivable that local architectural constraints
influence interaction with other co-factors (Additional
file 3: Table S2). Whatever the proximate cause, the
differences in local nucleosome architecture around
GATA3 binding sites prior to GATA3 expression at loci
that differ in outcome (nucleosome sliding versus evic-
tion) (Fig. 3b, c) suggest architectural constraints may
distinguish the two types of events. Architectural influ-
ences of DNA, and by extension chromatin, on outcomes
of TF mediated events have been elegantly documented in
the case of the glucocorticoid receptor [55].
GATA3 has been identified as one of the most fre-
quently mutated genes in breast cancer [35, 56]. GATA3
mutations accumulate in a striking pattern at the C-
terminal region of the protein including the second zinc
finger [56, 57]. Mutations in the DNA-binding domain
have been shown to affect chromatin binding activity and
motif recognition [43] and are likely to lead to alterations
in genomic distribution. The outcomes of mutations at
the far carboxyl terminus of GATA3, an abundant class of
cancer-specific mutants, are currently understudied.
Because most cancer-derived mutants have an intact N-
terminal domain, their abnormal distribution may induce
inappropriate pioneering activity leading to repro-
grammed gene expression. It is also conceivable that the
cancer-specific mutations in GATA3 alter co-factor re-
cruitment and interaction (either positively or negatively)
leading to novel or impaired pioneering functions. In
luminal breast cancer cells, GATA3 is known to function-
ally interact with the TFs FOXA1 and estrogen receptor-α
[28, 58], leading to the potential for GATA3 mutations to
alter the transcriptional network of these factors. Given
the capacity of GATA3 to catalyze cellular reprogramming
relevant to cancer biology, characterization of the impact
of cancer-specific mutations in this pioneering TF repre-
sents a field or enquiry with major clinical ramifications.
Conclusions
Our data provide new experimental evidence that GATA3
functions as a pioneer factor during cellular reprogram-
ming using the MET of breast cancer cells as a model.
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Dissection of chromatin features during this process
reveals key mechanistic features required to generate
active chromatin structure: binding to a nucleosomal
locus in the appropriate context and transactivation
domain dependent co-factor recruitment. These findings
provide novel insights into the mechanism of de novo
enhancer establishment by a pioneer TF.
Methods
Generation of stable cell line
Lentiviruses were produced by transient transfection of
293T cells with pHAGE, psPAX2, and pMD2.G plas-
mids. psPAX2 and pMD2.G were gifts from Didier
Trono (Addgene plasmid #12260, #12259). The virus-
containing medium and polybrene (at a final concentra-
tion of 8 μg/mL) were added to MDA-MB-231 cells.
Infected cells were selected with 0.5 μg/mL puromycin.
Only early passage cells (passages 3 to 7) were used in
all experiments. Cells expressing either GFP or the tag
alone (including the TEV protease recognition site) were
used as a control cell line.
Nucleosome binding assay
The reconstituted nucleosomes and GATA3 DBD were
incubated at room temperature for 30 min in the
reaction buffer containing 30 mM Tris-HCl (pH 7.5),
120 mM NaCl, 25 mM KCl, 4 % glycerol, 1.5 % Ficoll
400, 0.4 mM zinc sulphate, and 0.1 mM EDTA. The
complex and free nucleosomes were separated on 6 %
native-polyacrylamide gel, and visualized by ethidium
bromide staining.
ATAC-seq sample preparation and data analysis
The sequence library for ATAC-seq was prepared as pre-
viously described [44] with several modifications (see
Additional file 1: supplementary methods). Reads were
mapped to hg19 genome using Bowtie 0.12.8 [59] with
the same parameter used in [44]. Only non-duplicate
reads were used for the subsequent analysis. The offset
parameters suggested by Buenrostro et al. were ap-
plied to each mapped read [44]. Reads from three
biological replicates were then merged for use in all
subsequent analysis.
MNase-seq
Native mononucleosomes were prepared as previously
described [60] with several modifications (see Additional
file 1: supplementary methods). Briefly, cells were treated
with a hypotonic buffer for 15 min on ice. The isolated
chromatin was digested with 4 U of MNase at 37 °C for
4 min. Digested chromatin was homogenized by pass-
ing through a 27G ½ needle (8 strokes), and the debris
was removed by centrifugation. DNA was purified using
a spin column. Mononucleosomes were separated by
agarose gel electrophoresis, and purified by a QIAGEN
gel extraction kit. Sequencing libraries were prepared
by NEXTflex Rapid DNA-Seq kit. Reads were mapped
to hg19 genome, and duplicate reads were removed
using MarkDuplicates.jar from picard-tools-1.107 pack-
age (http://broadinstitute.github.io/picard/). All paired-
end reads were converted to a single fragment for the
metagene plot analysis.
Chromatin immunoprecipitation (ChIP) for histones and
BRG1
ChIP experiments were performed as previously described
[61] with the following modifications. Cells were fixed
with 1 % formaldehyde either at room temperature for
10 min (histone ChIP) or at 37 °C for 20 min (BRG1
ChIP), and quenched with glycine. For BRG1 ChIP, fixed
cells were further treated with a hypotonic buffer. Cell
pellets were resuspended with lysis buffer A (20 mM Tris-
HCl pH 8.0, 2 mM EDTA, 0.5 mM EGTA, 0.5 mM PMSF,
5 mM sodium butyrate, 1 % SDS and protease inhibitor
cocktail) for histone ChIP or lysis buffer B (same as buffer
A, except 0.1 % SDS) for BRG1 ChIP. Chromatin was
fragmented by sonication with Bioruptor (histone ChIP),
or Covaris S220 (BRG1 ChIP), then diluted to adjust the
SDS concentration to 0.1 % or 0.05 %. Immunoprecipita-
tion was performed with indicated antibodies (Additional
file 1: Table S5). Dynabeads Protein A and G were used to
capture antibodies, and beads were washed with 1 mL of
low salt (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM
EDTA, 1 % Triton X-100, 0.1 % SDS), high salt (same as
low salt buffer, except 500 mM NaCl), and LiCl buffer
(Tris-HCl pH 8.0, 250 mM LiCl, 2 mM EDTA, 1 % NP-
40, 1 % (wt/vol) sodium deoxycholate). Eluted DNA was
treated with RNase at 65 °C, followed by the incubation
with proteinase K. DNA was purified by AMPure XP.
Histone and BRG1 ChIP experiments were conducted
with two and three biological replicates, respectively
(Additional file 1: Table S5).
ChIP for GATA3
Cells were treated with CSK buffer 2 (same as described
above, except containing 1 mM EGTA, 2 mM EDTA,
1 mM PMSF, and protease inhibitor cocktail) for 5 min
on ice or at 37 °C. After centrifugation at 100 g for
5 min at 4 °C, nuclear pellets were washed with CSK
buffer 3 (same as CSK buffer1, except that Triton X-100
was omitted). After centrifugation, nuclei were resus-
pended with CSK buffer 3, then an equal volume of 2 %
formaldehyde containing CSK buffer 3 was added to the
solution, followed by the incubation at 4 °C for 15 min.
The fixation was quenched by addition of glycine, and
the fixed nuclei were washed twice with CSK buffer 3.
The nuclei were lysed with 0.5 % SDS containing lysis
buffer A, and chromatin was fragmented by sonication
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with Bioruptor. The fragmented chromatin was diluted
with nine-fold volume of IP buffer (20 mM Tris-HCl
pH 8.0, 150 mM NaCl, 2 mM EDTA, 10 % glycerol,
0.5 % Triton X-100, 0.5 mM PMSF, 5 mM sodium butyr-
ate, and protease inhibitor cocktail). Immunoprecipitation
was performed as described above with two biological rep-
licates (Additional file 1: Table S5). Homemade GATA3
antibody (prepared in Wade laboratory) was used for ChIP
experiments [43], and Ty1 antibody was prepared in
Stunnenberg laboratory [62].
ChIP-seq analysis
Reads were filtered based on a mean base quality score
>20, and mapped to hg19 genome using Bowtie 0.12.8
[59]. In order to minimize PCR amplification bias, dupli-
cate reads were removed using MarkDuplicates.jar from
picard-tools-1.107 package. Reads from the biological
replicates were merged for use in all subsequent analysis.
All paired-end reads were converted to a single fragment
for the metagene plot analysis and visualization on the
UCSC Genome Browser. After normalization to the
indicated counts (Additional file 1: Table S6), bigWig
files were generated to visualize the genomic coverage.
Peak call and motif analysis
Peak calling and motif analyses were performed using
HOMER v4.1 with default parameters [63]. Motif length
8, 10, and 12 bases were used for de novo motif analysis.
Based on the distance from the midpoint of a peak to
the nearest RefSeq transcription start site, we defined all
peaks as either TSS-proximal (distance: less than or
equal to 1 kb) or distal (distance: more than 1 kb) peaks.
GATA3 peak classification based on ATAC-seq
EdgeR [64] was used to divide the GATA3 peaks into
three groups (signal stronger: G1, signal conserved, and
signal reduced: G3) based on the signal changes of
ATAC-seq before and after GATA3-induced epithelial
transition. After normalization to 30 million total reads,
ATAC-seq read counts in the 200 bp window centered
on GATA3 peaks were collected. The following parame-
ters were used for the peak classification: FDR <0.1 and
fold change >2. The signal conserved group was further
subclassified into signal positive (G2) and negative (G3)
groups based on a threshold of 20 counts in the +/- 1 kb
region flanking the peak midpoint. In the heatmaps
(Figs. 2a, 5a, and 6d, Additional file 1: Figure S5A), the
peaks are ordered by decreasing weighted ATAC signal
within each of the four peak classes.
Statistical analysis
Box plots were generated by with bwplot (lattice R package;
for randomly selected GATA motif containing genomic re-
gions) or Prism 6 (GraphPad Software). Mann-Whitney test
was used to compare data groups. Asterisk indicates
P value <0.0001.
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